Lexeo Therapeutics Announces In-License Agreement With Cornell University To Expedite Development Of LX2006 For Treatment Of Friedreich Ataxia Cardiomyopathy; Under Agreement, Co. Has Acquired Certain Rights1 Including Rights To Current And Future Data Generated In An Ongoing Investigator-initiated Phase 1A Trial Of AAVrh.10hFXN To Treat Fa Cardiomyopathy
Lexeo Therapeutics宣佈與康奈爾大學簽訂許可協議，以加快開發用於治療弗裏德雷希共濟失調心肌病的 LX2006；根據協議，Co.已獲得某些權利1 包括研究人員發起的用於治療 Fa 心肌病的 Aavrh.10HFXN 1A 期臨床試驗中生成的當前和未來數據的權利